2022
Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B
Burke T, Shaikh A, Ali T, Li N, Curtis R, Diego D, Recht M, Sannie T, Skinner M, O’Hara J. Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B. Journal Of Medical Economics 2022, 25: 386-392. PMID: 35253589, DOI: 10.1080/13696998.2022.2049552.Peer-Reviewed Original ResearchConceptsDirect medical costsHemophilia BHealth-related quality of lifeMedical costsHealth-related qualityMedical recordsQuality of lifeGene therapy trialsFactor replacement therapyRetrospective cross-sectional analysisBody mass indexBlood-borne virusesEQ-5D questionnaireFunctional cureEQ-5D scoresConsecutive patientsTherapy trialsReplacement therapyMass indexCross-sectional analysisI-IIPatientsAssociation of increasesOffice visitsCost of care
2020
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial
Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial. Journal Of The American Heart Association 2020, 9: e016573. PMID: 32924754, PMCID: PMC7792388, DOI: 10.1161/jaha.120.016573.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesDouble-Blind MethodFemaleHealth Status IndicatorsHumansLower ExtremityMaleMiddle AgedOutcome Assessment, Health CarePeripheral Arterial DiseasePlatelet Aggregation InhibitorsQuality of LifeSurveys and QuestionnairesSymptom AssessmentTicagrelorVascular Surgical ProceduresVisual Analog ScaleConceptsMajor adverse cardiovascular eventsMajor adverse limb eventsAdverse cardiovascular eventsAdverse limb eventsLower extremity revascularizationPeripheral artery diseaseCardiovascular eventsHealth status instrumentsLimb eventsEUCLID trialVAS scoresArtery diseaseEQ-5DQuestionnaire scoresSubsequent major adverse cardiovascular eventsLow ankle-brachial indexSymptomatic peripheral artery diseaseLower extremity revascularization proceduresBaseline EQ-5DAnkle-brachial indexHealth status scoresEQ-5D scoresHealth status measurementHealth status changesSubsequent end points
2019
Health Utility Values as an Outcome Measure in Patients Undergoing Functional Septorhinoplasty
Gadkaree S, Fuller J, Justicz N, Weitzman R, Derakhshan A, Mohan S, Lindsay R. Health Utility Values as an Outcome Measure in Patients Undergoing Functional Septorhinoplasty. Facial Plastic Surgery & Aesthetic Medicine 2019, 21: 381-386. PMID: 31120515, PMCID: PMC6547223, DOI: 10.1001/jamafacial.2019.0234.Peer-Reviewed Original ResearchConceptsHealth utility valuesEQ-5D scoresOverall healthNasal obstructionMeasure health utility valuesFunctional septorhinoplastyEuroQol-5 DimensionsPopulation-based dataImprove overall healthPostoperative EQ-5D scoresEQ-5D questionnaireProspective cohort studyOutcome of septorhinoplastyChronic conditionsEQ-5D surveyEQ-5DUS populationChronic diseasesOutcome measuresCohort studyUtility valuesHealthSinus surgeryNasal surgeryFemale sexA Comparative Health Utility Value Analysis of Outcomes for Patients Following Septorhinoplasty With Previous Nasal Surgery
Gadkaree S, Fuller J, Justicz N, Derakhshan A, Mohan S, Yu P, Lindsay R. A Comparative Health Utility Value Analysis of Outcomes for Patients Following Septorhinoplasty With Previous Nasal Surgery. Facial Plastic Surgery & Aesthetic Medicine 2019, 21: 402-406. PMID: 31194223, PMCID: PMC6567843, DOI: 10.1001/jamafacial.2019.0176.Peer-Reviewed Original ResearchConceptsHealth utility valuesProspective cohort studyNasal surgerySingle-institution prospective cohort studyCohort studyFunctional rhinoplastyPredictors of outcomeHealth utilization outcomesEQ-5D scoresEQ-5D questionnaireAlar rim graftsAnalysis of outcomesCost-utility analysisSleep apneaNasal obstructionSurgical historyUtilization outcomesPrimary rhinoplastySurgical proceduresHealth statusMultivariate analysisSurgeryRim graftsOverall healthSpreader grafts
2014
Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction A VALIANT Study (Valsartan In Acute Myocardial Infarction)
Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, Califf RM, Rouleau JL, Kober L, White HD, Schulman KA, Reed SD. Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction A VALIANT Study (Valsartan In Acute Myocardial Infarction). JACC Heart Failure 2014, 2: 159-165. PMID: 24720924, DOI: 10.1016/j.jchf.2013.12.003.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAgedAngiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsBundle-Branch BlockCaptoprilDeath, Sudden, CardiacDrug Therapy, CombinationFemaleHealth StatusHeart FailureHospitalizationHumansMaleMyocardial InfarctionQuality of LifeRecurrenceStrokeSurvivorsTetrazolesTreatment OutcomeValineValsartanConceptsNonfatal CV eventsEQ-5D assessmentCV eventsVisual analog scaleEQ-5D scoresCardiovascular eventsMyocardial infarctionEQ-5DBaseline EQ-5D scoresKillip class IINonfatal cardiovascular eventsHealth-related qualityLinear mixed-effects regression modelsQuality of lifeMixed effects regression modelsVALIANT studyWorse HRQLVAS scoresEjection fractionNonfatal eventsMI survivorsAnalog scaleVALIANT trialGeneric instrumentsPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply